(RI) Pernod Ricard S.A. - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000120693
Stock: Whiskey, Vodka, Gin, Rum, Liqueur
Total Rating 39
Risk 84
Buy Signal -0.45
| Risk 5d forecast | |
|---|---|
| Volatility | 32.4% |
| Relative Tail Risk | -8.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.81 |
| Alpha | -30.83 |
| Character TTM | |
|---|---|
| Beta | 0.559 |
| Beta Downside | 0.505 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.61% |
| CAGR/Max DD | -0.40 |
Description: RI Pernod Ricard S.A. February 27, 2026
Pernod Ricard S.A. (ticker RI) is a global producer and distributor of wines, spirits, and a growing line of non-alcoholic beverages. Its portfolio spans iconic brands such as Absolut, Chivas, Jameson, Martell, and Pernod, alongside newer zero-alcohol offerings like Beefeater 0% and Ceder’s, covering categories from whisky and vodka to champagne and aperitifs.
In FY 2023 the group generated €10.2 billion in net sales, reflecting a 7% year-over-year increase and 5.5% organic growth, while adjusted EBITDA margin held steady at 22.3%. Net debt stood at €4.1 billion, giving a net-debt-to-equity ratio of roughly 0.45, indicating a manageable leverage profile.
Key sector drivers include continued premiumisation-premium-segment spirits grew 9% in 2023-and a resurgence in European on-trade consumption post-pandemic. Emerging-market demand, particularly for high-end whisky in China and India, remains a growth catalyst, while inflation-linked price pressures are being offset by strong brand pricing power.
For deeper quantitative insights, you might explore ValueRay’s detailed analyst toolkit.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 3.17b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.19 > 1.0 |
| NWC/Revenue: 36.65% < 20% (prev 54.92%; Δ -18.27% < -1%) |
| CFO/TA 0.11 > 3% & CFO 4.33b > Net Income 3.17b |
| Net Debt (11.54b) to EBITDA (6.15b): 1.88 < 3 |
| Current Ratio: 2.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (252.1m) vs 12m ago 0.32% < -2% |
| Gross Margin: 59.81% > 18% (prev 0.60%; Δ 5921 % > 0.5%) |
| Asset Turnover: 52.87% > 50% (prev 29.60%; Δ 23.28% > 0%) |
| Interest Coverage Ratio: 5.55 > 6 (EBITDA TTM 6.15b / Interest Expense TTM 997.5m) |
Altman Z'' 4.71
| A: 0.20 (Total Current Assets 13.04b - Total Current Liabilities 5.60b) / Total Assets 37.68b |
| B: 0.36 (Retained Earnings 13.42b / Total Assets 37.68b) |
| C: 0.14 (EBIT TTM 5.54b / Avg Total Assets 38.43b) |
| D: 1.23 (Book Value of Equity 25.94b / Total Liabilities 21.15b) |
| Altman-Z'' Score: 4.71 = AA |
Beneish M -2.72
| DSRI: 0.76 (Receivables 2.10b/1.58b, Revenue 20.32b/11.60b) |
| GMI: 1.01 (GM 59.81% / 60.14%) |
| AQI: 0.98 (AQ_t 0.54 / AQ_t-1 0.55) |
| SGI: 1.75 (Revenue 20.32b / 11.60b) |
| TATA: -0.03 (NI 3.17b - CFO 4.33b) / TA 37.68b) |
| Beneish M-Score: -2.72 (Cap -4..+1) = A |
What is the price of RI shares?
As of March 02, 2026, the stock is trading at EUR 78.26 with a total of 1,355,286 shares traded.
Over the past week, the price has changed by -6.61%, over one month by +4.91%, over three months by -0.51% and over the past year by -20.29%.
Over the past week, the price has changed by -6.61%, over one month by +4.91%, over three months by -0.51% and over the past year by -20.29%.
Is RI a buy, sell or hold?
Pernod Ricard S.A. has no consensus analysts rating.
What are the forecasts/targets for the RI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 94.6 | 20.9% |
| Analysts Target Price | - | - |
RI Fundamental Data Overview March 02, 2026
Market Cap USD = 23.24b (19.71b EUR * 1.1794 EUR.USD)
P/E Trailing = 12.1333
P/E Forward = 13.089
P/S = 1.9636
P/B = 1.2955
P/EG = 2.1006
Revenue TTM = 20.32b EUR
EBIT TTM = 5.54b EUR
EBITDA TTM = 6.15b EUR
Long Term Debt = 11.60b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.68b EUR (from shortTermDebt, last quarter)
Debt = 13.93b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.54b EUR (from netDebt column, last quarter)
Enterprise Value = 31.24b EUR (19.71b + Debt 13.93b - CCE 2.40b)
Interest Coverage Ratio = 5.55 (Ebit TTM 5.54b / Interest Expense TTM 997.5m)
EV/FCF = 19.91x (Enterprise Value 31.24b / FCF TTM 1.57b)
FCF Yield = 5.02% (FCF TTM 1.57b / Enterprise Value 31.24b)
FCF Margin = 7.72% (FCF TTM 1.57b / Revenue TTM 20.32b)
Net Margin = 15.62% (Net Income TTM 3.17b / Revenue TTM 20.32b)
Gross Margin = 59.81% ((Revenue TTM 20.32b - Cost of Revenue TTM 8.17b) / Revenue TTM)
Gross Margin QoQ = 59.28% (prev 57.35%)
Tobins Q-Ratio = 0.83 (Enterprise Value 31.24b / Total Assets 37.68b)
Interest Expense / Debt = 1.74% (Interest Expense 243.0m / Debt 13.93b)
Taxrate = 26.25% (357.0m / 1.36b)
NOPAT = 4.08b (EBIT 5.54b * (1 - 26.25%))
Current Ratio = 2.33 (Total Current Assets 13.04b / Total Current Liabilities 5.60b)
Debt / Equity = 0.90 (Debt 13.93b / totalStockholderEquity, last quarter 15.47b)
Debt / EBITDA = 1.88 (Net Debt 11.54b / EBITDA 6.15b)
Debt / FCF = 7.35 (Net Debt 11.54b / FCF TTM 1.57b)
Total Stockholder Equity = 15.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.26% (Net Income 3.17b / Total Assets 37.68b)
RoE = 20.16% (Net Income TTM 3.17b / Total Stockholder Equity 15.74b)
RoCE = 20.25% (EBIT 5.54b / Capital Employed (Equity 15.74b + L.T.Debt 11.60b))
RoIC = 14.23% (NOPAT 4.08b / Invested Capital 28.68b)
WACC = 5.20% (E(19.71b)/V(33.64b) * Re(7.97%) + D(13.93b)/V(33.64b) * Rd(1.74%) * (1-Tc(0.26)))
Discount Rate = 7.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.26%
[DCF] Terminal Value 88.43% ; FCFF base≈1.25b ; Y1≈1.54b ; Y5≈2.63b
[DCF] Fair Price = 258.0 (EV 76.51b - Net Debt 11.54b = Equity 64.97b / Shares 251.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 2.77 | EPS CAGR: -53.79% | SUE: 0.0 | # QB: 0
Revenue Correlation: -34.83 | Revenue CAGR: -5.45% | SUE: N/A | # QB: 0
EPS current Year (2026-06-30): EPS=5.88 | Chg7d=-0.073 | Chg30d=-0.167 | Revisions Net=-7 | Growth EPS=-19.0% | Growth Revenue=-11.7%
EPS next Year (2027-06-30): EPS=6.06 | Chg7d=-0.061 | Chg30d=-0.150 | Revisions Net=-6 | Growth EPS=+3.0% | Growth Revenue=+1.1%
[Analyst] Revisions Ratio: -0.54 (3 Up / 10 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -0.3% (Discount Rate 8.0% - Earnings Yield 8.2%)
[Growth] Growth Spread = +1.4% (Analyst 1.1% - Implied -0.3%)
P/E Trailing = 12.1333
P/E Forward = 13.089
P/S = 1.9636
P/B = 1.2955
P/EG = 2.1006
Revenue TTM = 20.32b EUR
EBIT TTM = 5.54b EUR
EBITDA TTM = 6.15b EUR
Long Term Debt = 11.60b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.68b EUR (from shortTermDebt, last quarter)
Debt = 13.93b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.54b EUR (from netDebt column, last quarter)
Enterprise Value = 31.24b EUR (19.71b + Debt 13.93b - CCE 2.40b)
Interest Coverage Ratio = 5.55 (Ebit TTM 5.54b / Interest Expense TTM 997.5m)
EV/FCF = 19.91x (Enterprise Value 31.24b / FCF TTM 1.57b)
FCF Yield = 5.02% (FCF TTM 1.57b / Enterprise Value 31.24b)
FCF Margin = 7.72% (FCF TTM 1.57b / Revenue TTM 20.32b)
Net Margin = 15.62% (Net Income TTM 3.17b / Revenue TTM 20.32b)
Gross Margin = 59.81% ((Revenue TTM 20.32b - Cost of Revenue TTM 8.17b) / Revenue TTM)
Gross Margin QoQ = 59.28% (prev 57.35%)
Tobins Q-Ratio = 0.83 (Enterprise Value 31.24b / Total Assets 37.68b)
Interest Expense / Debt = 1.74% (Interest Expense 243.0m / Debt 13.93b)
Taxrate = 26.25% (357.0m / 1.36b)
NOPAT = 4.08b (EBIT 5.54b * (1 - 26.25%))
Current Ratio = 2.33 (Total Current Assets 13.04b / Total Current Liabilities 5.60b)
Debt / Equity = 0.90 (Debt 13.93b / totalStockholderEquity, last quarter 15.47b)
Debt / EBITDA = 1.88 (Net Debt 11.54b / EBITDA 6.15b)
Debt / FCF = 7.35 (Net Debt 11.54b / FCF TTM 1.57b)
Total Stockholder Equity = 15.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.26% (Net Income 3.17b / Total Assets 37.68b)
RoE = 20.16% (Net Income TTM 3.17b / Total Stockholder Equity 15.74b)
RoCE = 20.25% (EBIT 5.54b / Capital Employed (Equity 15.74b + L.T.Debt 11.60b))
RoIC = 14.23% (NOPAT 4.08b / Invested Capital 28.68b)
WACC = 5.20% (E(19.71b)/V(33.64b) * Re(7.97%) + D(13.93b)/V(33.64b) * Rd(1.74%) * (1-Tc(0.26)))
Discount Rate = 7.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.26%
[DCF] Terminal Value 88.43% ; FCFF base≈1.25b ; Y1≈1.54b ; Y5≈2.63b
[DCF] Fair Price = 258.0 (EV 76.51b - Net Debt 11.54b = Equity 64.97b / Shares 251.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 2.77 | EPS CAGR: -53.79% | SUE: 0.0 | # QB: 0
Revenue Correlation: -34.83 | Revenue CAGR: -5.45% | SUE: N/A | # QB: 0
EPS current Year (2026-06-30): EPS=5.88 | Chg7d=-0.073 | Chg30d=-0.167 | Revisions Net=-7 | Growth EPS=-19.0% | Growth Revenue=-11.7%
EPS next Year (2027-06-30): EPS=6.06 | Chg7d=-0.061 | Chg30d=-0.150 | Revisions Net=-6 | Growth EPS=+3.0% | Growth Revenue=+1.1%
[Analyst] Revisions Ratio: -0.54 (3 Up / 10 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -0.3% (Discount Rate 8.0% - Earnings Yield 8.2%)
[Growth] Growth Spread = +1.4% (Analyst 1.1% - Implied -0.3%)